Improving Veteran Access to Integrated Management of Back Pain (AIM-Back): Protocol for an Embedded Pragmatic Cluster-Randomized Trial
Steven Z George, Cynthia J Coffman, Kelli D Allen, Trevor A Lentz, Ashley Choate, Adam P Goode, Corey B Simon, Janet M Grubber, Heather King, Chad E Cook, Francis J Keefe, Lindsay A Ballengee, Jennifer Naylor, Joseph Leo Brothers, Catherine Stanwyck, Aviel Alkon, Susan N Hastings, Steven Z George, Cynthia J Coffman, Kelli D Allen, Trevor A Lentz, Ashley Choate, Adam P Goode, Corey B Simon, Janet M Grubber, Heather King, Chad E Cook, Francis J Keefe, Lindsay A Ballengee, Jennifer Naylor, Joseph Leo Brothers, Catherine Stanwyck, Aviel Alkon, Susan N Hastings
Abstract
Background: Coordinated efforts between the National Institutes of Health, the Department of Defense, and the Department of Veterans Affairs have built the capacity for large-scale clinical research investigating the effectiveness of nonpharmacologic pain treatments. This is an encouraging development; however, what constitutes best practice for nonpharmacologic management of low back pain (LBP) is largely unknown.
Design: The Improving Veteran Access to Integrated Management of Back Pain (AIM-Back) trial is an embedded pragmatic cluster-randomized trial that will examine the effectiveness of two different care pathways for LBP. Sixteen primary care clinics will be randomized 1:1 to receive training in delivery of 1) an integrated sequenced-care pathway or 2) a coordinated pain navigator pathway. Primary outcomes are pain interference and physical function (Patient-Reported Outcomes Measurement Information System Short Form [PROMIS-SF]) collected in the electronic health record at 3 months (n=1,680). A subset of veteran participants (n=848) have consented to complete additional surveys at baseline and at 3, 6, and 12 months for supplementary pain and other measures.
Summary: AIM-Back care pathways will be tested for effectiveness, and treatment heterogeneity will be investigated to identify which veterans may respond best to a given pathway. Health care utilization patterns (including opioid use) will also be compared between care pathways. Therefore, the AIM-Back trial will provide important information that can inform the future delivery of nonpharmacologic treatment of LBP.
Keywords: Care Pathways; Nonpharmacologic; Pain Interference; Pain Management; Physical Function.
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
References
- Kerns RD, Brandt CA, Peduzzi P. NIH-DoD-VA Pain Management Collaboratory. Pain Med 2019;20(12):2336–45.
- Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA 2016;315(15):1624–45.
- National Academies of Sciences, Engineering, and Medicine. The Role of Nonpharmacological Approaches to Pain Management: Proceedings of a Workshop. Washington, DC: National Academies Press; 2019.
- Chou R, Deyo R, Friedly J, et al. AHRQ Comparative Effectiveness Reviews. Noninvasive Treatments for Low Back Pain. Rockville, MD: Agency for Healthcare Research and Quality (US; ); 2016.
- Chou R, Deyo R, Friedly J, et al. Nonpharmacologic therapies for low back pain: A systematic review for an American College of Physicians clinical practice guideline. Ann Intern Med 2017;166(7):493–505.
- Childs JD, Fritz JM, Wu SS, et al. Implications of early and guideline adherent physical therapy for low back pain on utilization and costs. BMC Health Serv Res 2015;15(1):150.
- Frogner BK, Harwood K, Andrilla CHA, Schwartz M, Pines JM. Physical therapy as the first point of care to treat low back pain: An instrumental variables approach to estimate impact on opioid prescription, health care utilization, and costs. Health Serv Res 2018;53(6):4629–46.
- Kazis LE, Ameli O, Rothendler J, et al. Observational retrospective study of the association of initial healthcare provider for new-onset low back pain with early and long-term opioid use. BMJ Open 2019;9(9):e028633.
- Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of chronic pain and high-impact chronic pain among adults—United States, 2016. MMWR Morbid Mortality Wkly Rep 2018;67(36):1001–6.
- Io M. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: National Academies Press; 2011.
- Amtmann D, Kim J, Chung H, Askew RL, Park R, Cook KF. Minimally important differences for Patient Reported Outcomes Measurement Information System pain interference for individuals with back pain. J Pain Res 2016;9:251–5.
- Deyo RA, Dworkin SF, Amtmann D, et al. Report of the NIH Task Force on research standards for chronic low back pain. J Pain 2014;15(6):569–85.
- Collins LM, Schafer JL, Kam CM. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods 2001;6(4):330–51.
- Gurung T, Ellard DR, Mistry D, Patel S, Underwood M. Identifying potential moderators for response to treatment in low back pain: A systematic review. Physiotherapy 2015;101(3):243–51.
- Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
- Goode AP, Taylor SS, Hastings SN, Stanwyck C, Coffman CJ, Allen KD. Effects of a home-based telephone-supported physical activity program for older adult veterans with chronic low back pain. Phys Ther 2018;98(5):369–80.
- Kahan BC. Accounting for centre-effects in multicentre trials with a binary outcome - When, why, and how? BMC Med Res Methodol 2014;14(1):20.
- Mallinckrodt CH. Preventing and Treating Missing Data in Longitudinal Clinical Trials: A Practical Guide. Cambridge: Cambridge University Press; 2013.
- Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: A proposal. Trials 2010;11(1):85.
- Murray DD. Design and Analysis of Group Randomized Trials. New York: Oxford University Press; 1998.
- Kerns RD, Philip EJ, Lee AW, Rosenberger PH. Implementation of the Veterans Health Administration national pain management strategy. Transl Behav Med 2011;1(4):635–43.
- Li F, Turner EL, Heagerty PJ, Murray DM, Vollmer WM, DeLong ER. An evaluation of constrained randomization for the design and analysis of group-randomized trials with binary outcomes. Stat Med 2017;36(24):3791–806.
- Lipkovich I, Dmitrienko A, D’Agostino RB Sr. Tutorial in biostatistics: Data-driven subgroup identification and analysis in clinical trials. Stat Med 2017;36(1):136–96.
- Localio AR, Berlin JA, Ten Have TR, Kimmel SE. Adjustments for center in multicenter studies: An overview. Ann Intern Med 2001;135(2):112–23.
- Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: Designing trials that are fit for purpose. BMJ 2015;350:h2147.
- Interagency Pain Research Coordinating Committee. National pain strategy: A comprehensive population health level strategy for pain In: HaH Services ed. Washington, DC: National Institutes of Health; 2015.
- Mattocks K, Rosen MI, Sellinger J, et al. Pain care in the Department of Veterans Affairs: Understanding how a cultural shift in pain care impacts provider decisions and collaboration. Pain Med 2020;21(5):970–7.
- Ha G. Longitudinal Data Analysis. Hoboken, NJ: Wiley & Sons; 2006.
- Carter BR, Hood K. Balance algorithm for cluster randomized trials. BMC Med Res Methodol 2008;8(1):65.
- Nahin RL. Severe pain in Veterans: The effect of age and sex, and comparisons with the general population. J Pain 2017;18(3):247–54.
- Von Korff M, Saunders K, Thomas Ray G, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain 2008;24(6):521–7.
- Raab GM, Butcher I. Balance in cluster randomized trials. Stat Med 2001;20(3):351–65.
- Ratitch B, O’Kelly M, Tosiello R. Missing data in clinical trials: From clinical assumptions to statistical analysis using pattern mixture models. Pharm Stat 2013;12(6):337–47.
- Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 2012;307(9):940–7.
- Simon GE, Platt R, Hernandez AF. Evidence from pragmatic trials during routine care—Slouching toward a learning health system. N Engl J Med 2020;382(16):1488–91.
- Turner EL, Li F, Gallis JA, Prague M, Murray DM. Review of recent methodological developments in group-randomized trials: Part 1—Design. Am J Public Health 2017;107(6):907–15.
- Tuzzio L, Larson EB, Chambers DA, et al. Pragmatic clinical trials offer unique opportunities for disseminating, implementing, and sustaining evidence-based practices into clinical care: Proceedings of a workshop. Healthc (Amst) 2019;7(1):51–7.
- Vanneman ME, Larson MJ, Chen C, et al. Treatment of low back pain with opioids and nonpharmacologic treatment modalities for Army veterans. Med Care 2018;56(10):855–61.
- George SZ, Goertz C, Hastings SN, Fritz JM. Transforming low back pain care delivery in the United States. Pain 2020; Publish Ahead of Print:doi: 10.1097/j.pain.0000000000001989. Online ahead of print.
- Weinfurt KP, Hernandez AF, Coronado GD, et al. Pragmatic clinical trials embedded in healthcare systems: Generalizable lessons from the NIH Collaboratory. BMC Med Res Methodol 2017;17(1):144.
Source: PubMed